Picture of China SXT Pharmaceuticals logo

SXTC China SXT Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.54-10.3-2.75-5.74-5.93
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items0.0679.052.892.894.19
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.541.95-1.612.461.42
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities0.2390.934-1.320.268-0.081
Capital Expenditures-0.61-0.407-0.093-0.062-0.071
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-5.09-5.710.0160.058
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.61-5.5-5.81-0.047-0.012
Financing Cash Flow Items2.52-3.712.5-3.84-3.26
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9.043.0212.41.62.94
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8.63-26.072.211.8